Indian Rifampicin Exporters: Complete Supplier Ranking with Market Share — 780 Manufacturers (2026) — TransData Nexus

Q: Who is the largest rifampicin buyer importing from India?

CAMESKIN/CORDAID (CONGO DR) is the largest rifampicin importer from India with a 39.5% market share and import value of $532.5M.

Q: How many rifampicin buyers import from India?

There are 780 active rifampicin buyers importing from India, with a combined import market of $1.3B across 3,913 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top rifampicin buyers from India?

The top 5 rifampicin buyers — CAMESKIN/CORDAID, NATIONAL TUBERCULOSIS AND LEPROSY, LA PHARMACIE CENTRALE DE TUNISIE, DIRECTOR MBDC DGHS, SECRETARY FOR HEALTH AND CHILD CARE — together control 79.7% of total rifampicin import value from India.

Suresh Sormare

Rifampicin

India Pharmaceutical Trade Intelligence

$1.3B175 Suppliers162 CountriesHS 30049057

ExportsIndia → CONGO DR39.7%India → NIGERIA18.7%

ImportsUNITED STATES → India$125.6K UNITED KINGDOM → India$10.2K

#1 Supplier: LUPIN LIMITED #1 Buyer: CAMESKIN/CORDAID

Market Analysis: Top Importing Countries & Their Importers

1Congo Dr

Congo Dr emerges as the first largest importing country, achieving a total trade value of $536.0M through 6 shipments. This represents a market share of 39.7% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Congo Dr has a diverse importer base, with their top importers including:

• CAMESKIN/CORDAID - $532.5M (99.3% of country's total business)

Key Insight: Congo Dr demonstrates strong market positioning with an average shipment value of $89.3M, indicating premium pricing strategy compared to the market average of $344.9K.

Congo Dr is a key market for Rifampicin imports, representing 39.7% of total trade value.

Primary Market

Secondary Market

2Nigeria

Nigeria emerges as the second largest importing country, achieving a total trade value of $252.7M through 67 shipments. This represents a market share of 18.7% of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Rifampicin buyer market intelligence

1Buyer Segment Analysis

The importation of Rifampicin from India involves various buyer segments, each with distinct procurement behaviors:

Government Procurement Agencies: Entities such as CAMESKIN/CORDAID (Democratic Republic of Congo), NATIONAL TUBERCULOSIS AND LEPROSY (Nigeria), LA PHARMACIE CENTRALE DE TUNISIE (Tunisia), DIRECTOR MBDC DGHS (Bangladesh), SECRETARY FOR HEALTH AND CHILD CARE (Zimbabwe), NATIONAL PROGRAMME FOR TB (Sri Lanka), MINISTERIO DE SALUD PUBLICA Y (Guatemala), NATIONAL DRUG SERVICE ORGANISATION (Lesotho), and MINISTRY OF HEALTH OF THE REPUBLIC (Zambia) fall into this category. These organizations typically engage in large-scale, tender-based purchasing to supply national healthcare programs, ensuring consistent and cost-effective access to essential medicines. Their procurement cycles are often annual or bi-annual, aligning with budget allocations and public health initiatives.

Clinical Research Organizations: An example is CLINICAL RESEARCH PRODUCT (United States). These entities procure Rifampicin for clinical trials and research purposes. Their purchasing patterns are project-specific, with volumes and frequencies varying based on study requirements and timelines.

Understanding these segments is crucial for suppliers aiming to tailor their offerings and engagement strategies to meet the specific needs and procurement behaviors of each buyer type.

Country-Specific Import Regulations

TransData Nexus Rifampicin buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Rifampicin from India, the import regulations are as follows:

1. Democratic Republic of Congo (DRC):

Drug Regulatory Authority: Ministry of Public Health.

Import Registration Process: Importers must obtain authorization from the Ministry of Public Health, ensuring compliance with national pharmaceutical standards.

Estimated Timeline for Registration: Approximately 3 to 6 months, depending on the completeness of the application and regulatory reviews.

Import Tariff/Duty for HS 30049057: The DRC applies a tariff structure with rates of 5%, 10%, and 20% based on product classification. Pharmaceuticals typically fall under the 5% or 10% categories. Additionally, a value-added tax (VAT) of 16% applies to most imports.

2. Nigeria:

Drug Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).

Demand Drivers & Market Opportunity

TransData Nexus Rifampicin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Rifampicin in importing countries is primarily driven by several key factors:

Disease Prevalence: Tuberculosis (TB) remains a significant public health challenge globally. According to the World Health Organization (WHO), in 2022, approximately 10.6 million people fell ill with TB worldwide, underscoring the ongoing need for effective treatments like Rifampicin.

Government Healthcare Programs: Many countries have implemented national TB control programs aimed at reducing the incidence and mortality associated with the disease. These programs often include the procurement and distribution of essential medicines, including Rifampicin, to ensure widespread access to treatment.

Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased investment in healthcare infrastructure and services, facilitating better diagnosis and treatment of TB and other infectious diseases. This expansion enhances the accessibility of medications like Rifampicin to broader populations.

WHO Essential Medicines List Procurement: Rifampicin is listed on the WHO Model List of Essential Medicines, guiding countries in prioritizing its procurement to address critical health needs. This inclusion reinforces its importance in national healthcare systems and supports consistent demand.

Common Questions — Rifampicin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest rifampicin buyer importing from India?

Based on import volume and value, CAMESKIN/CORDAID (CONGO DR) leads with $532.5M in imports and a 39.5% market share — the highest of any single rifampicin importer. NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA) and LA PHARMACIE CENTRALE DE TUNISIE (TUNISIA) are the next largest buyers.

QHow many companies buy rifampicin from India?

There are 780 active rifampicin buyers importing from India, with a combined market of $1.3B across 3,913 shipments to 162 countries. The top 5 buyers hold 79.7% of total import value, while the remaining 775 buyers handle the other 20.3%.

QWhich countries import the most rifampicin from India?

The top importing countries for rifampicin from India are Congo Dr (39.7%), Nigeria (18.7%), Tunisia (10.7%), Bangladesh (7.1%), Zimbabwe (4.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of rifampicin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for rifampicin from India?

The average import transaction value for rifampicin from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Rifampicin buyer market intelligence

1Buyer Segment Analysis

The importation of Rifampicin from India involves various buyer segments, each with distinct procurement behaviors:

Government Procurement Agencies: Entities such as CAMESKIN/CORDAID (Democratic Republic of Congo), NATIONAL TUBERCULOSIS AND LEPROSY (Nigeria), LA PHARMACIE CENTRALE DE TUNISIE (Tunisia), DIRECTOR MBDC DGHS (Bangladesh), SECRETARY FOR HEALTH AND CHILD CARE (Zimbabwe), NATIONAL PROGRAMME FOR TB (Sri Lanka), MINISTERIO DE SALUD PUBLICA Y (Guatemala), NATIONAL DRUG SERVICE ORGANISATION (Lesotho), and MINISTRY OF HEALTH OF THE REPUBLIC (Zambia) fall into this category. These organizations typically engage in large-scale, tender-based purchasing to supply national healthcare programs, ensuring consistent and cost-effective access to essential medicines. Their procurement cycles are often annual or bi-annual, aligning with budget allocations and public health initiatives.

Clinical Research Organizations: An example is CLINICAL RESEARCH PRODUCT (United States). These entities procure Rifampicin for clinical trials and research purposes. Their purchasing patterns are project-specific, with volumes and frequencies varying based on study requirements and timelines.

Understanding these segments is crucial for suppliers aiming to tailor their offerings and engagement strategies to meet the specific needs and procurement behaviors of each buyer type.

Country-Specific Import Regulations

TransData Nexus Rifampicin buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Rifampicin from India, the import regulations are as follows:

1. Democratic Republic of Congo (DRC):

Drug Regulatory Authority: Ministry of Public Health.

Import Registration Process: Importers must obtain authorization from the Ministry of Public Health, ensuring compliance with national pharmaceutical standards.

Estimated Timeline for Registration: Approximately 3 to 6 months, depending on the completeness of the application and regulatory reviews.

2. Nigeria:

Drug Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).

Demand Drivers & Market Opportunity

TransData Nexus Rifampicin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Rifampicin in importing countries is primarily driven by several key factors:

Disease Prevalence: Tuberculosis (TB) remains a significant public health challenge globally. According to the World Health Organization (WHO), in 2022, approximately 10.6 million people fell ill with TB worldwide, underscoring the ongoing need for effective treatments like Rifampicin.

Government Healthcare Programs: Many countries have implemented national TB control programs aimed at reducing the incidence and mortality associated with the disease. These programs often include the procurement and distribution of essential medicines, including Rifampicin, to ensure widespread access to treatment.

Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased investment in healthcare infrastructure and services, facilitating better diagnosis and treatment of TB and other infectious diseases. This expansion enhances the accessibility of medications like Rifampicin to broader populations.

WHO Essential Medicines List Procurement: Rifampicin is listed on the WHO Model List of Essential Medicines, guiding countries in prioritizing its procurement to address critical health needs. This inclusion reinforces its importance in national healthcare systems and supports consistent demand.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Rifampicin

Rifampicin

Who Buys Rifampicin from India — 780 Importers Behind a $1.3B Market

Top Rifampicin Importers — Ranked by Import Value

Top Rifampicin Buyers & Importers

Related Analysis

Need Details?

Rifampicin — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Rifampicin — and from which countries?

Rifampicin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Congo Dr

2Nigeria

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Rifampicin Buyers & Importers

QWho is the largest rifampicin buyer importing from India?

QHow many companies buy rifampicin from India?

QWhich countries import the most rifampicin from India?

QWhat is the average import order value for rifampicin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Tunisia

4Bangladesh

5Zimbabwe

Analysis Methodology